Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.020
+0.070 (3.59%)
At close: Aug 4, 2025, 4:00 PM
1.990
-0.030 (-1.49%)
After-hours: Aug 4, 2025, 7:41 PM EDT
Cronos Group Revenue
Cronos Group had revenue of $32.26M in the quarter ending March 31, 2025, with 27.58% growth. This brings the company's revenue in the last twelve months to $124.59M, up 33.92% year-over-year. In the year 2024, Cronos Group had annual revenue of $117.62M with 34.82% growth.
Revenue (ttm)
$124.59M
Revenue Growth
+33.92%
P/S Ratio
6.03
Revenue / Employee
$271,436
Employees
459
Market Cap
751.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CRON News
- 4 days ago - Top Canadian Pot Stocks Gaining Attention in August 2025 - MarijuanaStocks
- 10 days ago - Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025 - GlobeNewsWire
- 16 days ago - Top Canadian Cannabis Picks for U.S. Market Expansion in 2025 - MarijuanaStocks
- 19 days ago - High Tide Closes on $30 Million Convertible Debt from Cronos Group Inc. - PRNewsWire
- 21 days ago - 3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce - MarijuanaStocks
- 24 days ago - 3 Marijuana Stocks To Watch: Key Trends Driving Cannabis Industry Growth - MarijuanaStocks
- 4 weeks ago - Americans Should Buy Canadian Cannabis Companies - Seeking Alpha
- 4 weeks ago - Cronos Grows its International Footprint in Switzerland - GlobeNewsWire